Vascudyne has a total of 23 patents globally, out of which 2 have been granted. Of these 23 patents, more than 69% patents are active. Europe (EPO) and Australia are where Vascudyne has filed the maximum number of patents, followed by Israel and India. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Vascudyne.
Vascudyne was founded in 2014. The company operates in the biotechnology sector with a focus on developing, manufacturing, and commercializing regenerative, acellular, in-vitro-grown tissue. Its primary innovation lies in creating tissue-based coronary bypass grafts, with the aim of accelerating commercialization and bringing this breakthrough technology from the lab into surgical practice. By doing so, the company empowers surgeons with advanced solutions and enables patients in need of tissue replacement and repair to benefit from next-generation treatments.
Do read about some of the most popular patents of Vascudyne which have been covered by us in this article and also you can find Vascudyne patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vascudyne patent portfolio.
How many patents does Vascudyne have?
Vascudyne has a total of 23 patents globally. These patents belong to 7 unique patent families. Out of 23 patents, 16 patents are active.
How Many Patents did Vascudyne File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Vascudyne Applications Filed | Vascudyne Patents Granted |
| 2024 | 5 | 1 |
| 2023 | 10 | – |
| 2021 | 4 | 1 |
| 2018 | 4 | – |
How many Vascudyne patents are Alive/Dead?
Worldwide Patents
How Many Patents did Vascudyne File in Different Countries?
Countries in which Vascudyne Filed Patents
| Country | Patents |
| Europe (EPO) | 4 |
| Australia | 4 |
| United States of America | 3 |
| Israel | 2 |
| South Africa | 1 |
| New Zealand | 1 |
| Canada | 1 |
Where are Research Centers of Vascudyne Patents Located?
The Research Centers of Vascudyne Patents is the United States of America.
What Percentage of Vascudyne US Patent Applications were Granted?
Vascudyne (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these no patent have been granted leading to a grant rate of 0%.
Below are the key stats of Vascudyne patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Vascudyne?
| Law Firm | Total Applications | Success Rate |
| Fish & Richardson PC | 2 | 0% |
| William J Bundren | 1 | 0% |
List of Vascudyne patents
| Vascudyne Patents | Title |
| US20250176963A1 | Nerve Wrap Using Constructed Tissue |
| EP4586959A1 | Improved Valve Incorporating Constructed Tissue |
| EP4496602A1 | Nerve Wrap Using Constructed Tissue |
| AU2021245193B2 | Regenerative Tissue And Natural Tissue Implants |
| US20240016981A1 | Regenerative Tissue Manufacturing Process |
| EP4259219A4 | Regenerative Tissue Manufacturing Process |
| WO2024220501A1 | External Support For A Tissue Implant |
| WO2024178118A1 | Coronary Artery Bypass Graft |
| WO2024059281A1 | Improved Valve Incorporating Constructed Tissue |
| IL315559A | Nerve Wrap Using Constructed Tissue |
| ZA202407669A | Nerve Wrap Using Constructed Tissue |
| AU2023240889A1 | Nerve Wrap Using Constructed Tissue |
| AU2024219809A1 | Regenerative Tissue And Natural Tissue Implants |
| WO2023196787A3 | Improved Constructed Tissue |
| WO2023183148A4 | Nerve Wrap Using Constructed Tissue |
| NZ815303A | Nerve Wrap Using Constructed Tissue |
| CA3254937A1 | Nerve Wrap Using Constructed Tissue |
| IL303556A | Regenerative Tissue Manufacturing Process |
| WO2022125838A1 | Regenerative Tissue Manufacturing Process |
| AU2018291035B2 | Regenerative Tissue And Natural Tissue Implants |
| EP3645068A4 | Regenerative Tissue And Natural Tissue Implants |
| US20200129667A1 | Regenerative Tissue And Natural Tissue Implants |
| WO2019006430A1 | Regenerative Tissue And Natural Tissue Implants |
What are Vascudyne key innovation segments?
What Technologies are Covered by Vascudyne?
The chart below distributes patents filed by Vascudyne in different countries on the basis of the technology protected in patents. It also represents the markets where Vascudyne thinks it’s important to protect particular technological inventions.
R&D Focus: How has Vascudyne search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Vascudyne?
